Nuwellis (NUWE) FCF Margin Growth (3y) (2016 - 2026)
Nuwellis (NUWE) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | Nuwellis | 212,054.30 | -3.71 Mn | 1.50 Mn | 8,502.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,502.00 |
| Mar 31, 2026 | 20,435.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,242.00 |
| Jun 30, 2025 | 5,665.00 |
| Mar 31, 2025 | 12,106.00 |
| Dec 31, 2024 | 18,899.00 |
| Sep 30, 2024 | 14,129.00 |
| Jun 30, 2024 | 2,892.00 |
| Mar 31, 2024 | 12,784.00 |
| Dec 31, 2023 | 6,469.00 |
| Sep 30, 2023 | 7,490.00 |
| Jun 30, 2023 | -7,752.00 |
| Mar 31, 2023 | 306.00 |
| Dec 31, 2022 | 16,221.00 |
| Sep 30, 2022 | 14,225.00 |
| Jun 30, 2022 | 6,508.00 |
| Mar 31, 2022 | 15,299.00 |
| Dec 31, 2021 | -7,210.00 |
| Sep 30, 2021 | 598.00 |